Publication date: Available online 4 April 2018
Source:European Journal of Radiology
Author(s): Su Joa Ahn, Jeong Min Lee, Won Chang, Sang Min Lee, Hyo-Jin Kang, Hyun-kyung Yang, Joon Koo Han
ObjectivesTo prospectively evaluate the clinical value of real-time ultrasonography (US) −computed tomography (CT)/magnetic resonance imaging (MRI) fusion imaging for percutaneous needle biopsy of focal liver lesions (FLLs), and to compare its biopsy success rate with that of conventional US-guided biopsy in a propensity-score matched group.MethodsThis study was approved by our Institutional Review Board and informed consent was obtained from all patients enrolled in the prospective study group. Ninety patients referred to the Department of Radiology for percutaneous biopsy of FLLs were enrolled in this study. Tumor visibility, attainment of a safe access route, and technical feasibility were assessed on conventional US first and later on real-time fusion imaging by one of four abdominal radiologists. Thereafter, differences in scores between real-time fusion imaging and conventional US were determined. In addition, overall diagnostic success rates of a real-time fusion imaging-guided biopsy group and a propensity-score matched, conventional US-guided biopsy group, consisting of 100 patients used as historical control, were compared.ResultsWith real-time fusion imaging, tumor visibility, attainment of a safe access route, and operator's technical feasibility were significantly improved compared with conventional US (P < .001). In addition, all invisible (n = 13) and not feasible (n = 10) FLLs on conventional US became visible and feasible for percutaneous US-guided biopsy after applying the fusion system. The diagnostic success rate of real-time fusion-guided biopsy was 94.4% (85/90), which was significantly better than that obtained with the conventional US-guided biopsy (94.4% vs. 83%, P < .03), with reduced biopsy procedure times (7.1 ± 3.5 vs. 9.7 ± 2.8, P < .02).ConclusionsReal-time US-CT/MR fusion imaging guidance was able to provide clinical value for percutaneous needle biopsy of FLLs by improving the diagnostic success rate of biopsy and by reducing procedure time.
from Imaging via alkiviadis.1961 on Inoreader https://ift.tt/2qxWsbu
Σάββατο 14 Απριλίου 2018
Clinical Utility of Real-time Ultrasound-multimodality Fusion Guidance for Percutaneous Biopsy of Focal Liver Lesions
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Objective The objective of this study were to find the annual case trend of inflammatory jawbone diseases and to investigate th...
-
The investigational third-generation nonsteroidal oral selective estrogen receptor degrader RAD1901 was associated with a 23% objective resp...
-
by Patrick P. Lowe, Benedek Gyongyosi, Abhishek Satishchandran, Arvin Iracheta-Vellve, Aditya Ambade, Yeonhee Cho, Karen Kodys, Donna Catala...
-
The new app from IBM will let crowds automatically coordinates mass displays at big sporting events or protests using their smartphone camer...
-
A magnetic Fe3O4/GO composite with potential for rapid solid-liquid separation through a magnetic field was synthesized using GO (graphene o...
-
Medicaid is slated to lose billions of dollars in funding, as are many medical, humanitarian and scientific organisations from #Alexandro...
-
Abstract Glutamine (GLUT) is a nonessential amino acid that can become conditionally essential under stress conditions, being able to act ...
-
Norges første retningslinje for rehabilitering av pasienter med ervervet overekstremitetsamputasjon er nå tilgjengelig på nett. Retningslin...
-
A new beginning Anirudh Kohli Indian Journal of Radiology and Imaging 2019 29(1):1-1 Is next-generation radiologist ready for the challenges...
-
Vol.68 No.1 from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2iwPjTH via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου